LEMAITRE VASCULAR, INC. (LMAT) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $3.24M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $3.24M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $3.24M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 220.21M USD | Liabilities |
| Borrowing debt | (m) | |
| Amounts owed to suppliers | 3.24M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Deferred Revenue · Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Deferred revenue due within one year | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Deferred revenue due after one year | (m) | Deferred Revenue · Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | 1.46M USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) | Deferred Revenue · Contract with Customer, Liability, Current · Deferred Revenue, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $21.16M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.24M | (m) | (m) | (m) | $220.21M | (m) | (m) | (m) | $1.46M | (m) |
| 2026-03-31 | (m) | $4.18M | (m) | (m) | (m) | $222.90M | (m) | (m) | (m) | $1.31M | (m) |
| 2025-12-31 | (m) | $3.65M | (m) | (m) | (m) | $222.17M | (m) | (m) | (m) | $1.47M | (m) |
| 2025-09-30 | (m) | $3.46M | (m) | (m) | (m) | $219.15M | (m) | (m) | (m) | $933.00K | (m) |
| 2025-06-30 | (m) | $4.91M | (m) | (m) | (m) | $214.91M | (m) | (m) | (m) | $934.00K | (m) |
| 2025-03-31 | (m) | $2.18M | (m) | (m) | (m) | $208.43M | (m) | (m) | (m) | $875.00K | (m) |
| 2024-12-31 | (m) | $1.76M | (m) | (m) | (m) | $214.53M | (m) | (m) | (m) | $831.00K | (m) |
| 2024-09-30 | (m) | $1.65M | (m) | (m) | (m) | $45.95M | (m) | (m) | (m) | $896.00K | (m) |
| 2024-06-30 | (m) | $2.00M | (m) | (m) | (m) | $43.55M | (m) | (m) | (m) | $2.18M | (m) |
| 2024-03-31 | (m) | $3.09M | (m) | (m) | (m) | $45.45M | (m) | (m) | (m) | $2.18M | (m) |
| 2023-12-31 | (m) | $3.73M | (m) | (m) | (m) | $48.88M | (m) | (m) | (m) | $2.27M | (m) |
| 2023-09-30 | (m) | $4.37M | (m) | (m) | (m) | $45.38M | (m) | (m) | (m) | $2.15M | (m) |
| 2023-06-30 | (m) | $3.52M | (m) | (m) | (m) | $42.64M | (m) | (m) | (m) | $2.26M | (m) |
| 2023-03-31 | (m) | $3.37M | (m) | (m) | (m) | $40.70M | (m) | (m) | (m) | $2.28M | (m) |
| 2022-12-31 | (m) | $2.90M | (m) | (m) | (m) | $42.27M | (m) | (m) | (m) | $2.17M | (m) |
| 2022-09-30 | (m) | $2.85M | (m) | (m) | (m) | $40.80M | (m) | (m) | (m) | $2.40M | (m) |
| 2022-06-30 | (m) | $2.84M | (m) | (m) | (m) | $41.39M | (m) | (m) | (m) | $2.50M | (m) |
| 2022-03-31 | (m) | $2.19M | (m) | (m) | (m) | $34.67M | (m) | (m) | (m) | $2.63M | (m) |
| 2021-12-31 | (m) | $2.34M | (m) | (m) | (m) | $38.65M | (m) | (m) | (m) | $2.70M | (m) |
| 2021-09-30 | (m) | $3.14M | (m) | (m) | (m) | $40.42M | (m) | (m) | (m) | $3.60M | (m) |
| 2021-06-30 | (m) | $2.06M | (m) | (m) | (m) | $60.67M | (m) | (m) | (m) | $4.55M | (m) |
| 2021-03-31 | (m) | $2.56M | (m) | (m) | (m) | $69.84M | (m) | (m) | (m) | $4.58M | (m) |
| 2020-12-31 | (m) | $2.39M | (m) | (m) | (m) | $80.24M | (m) | (m) | (m) | $4.64M | (m) |
| 2020-09-30 | (m) | $2.17M | (m) | (m) | (m) | $100.59M | (m) | (m) | (m) | $4.63M | (m) |
| 2020-06-30 | (m) | $1.24M | (m) | (m) | (m) | $103.09M | (m) | (m) | (m) | $5.02M | (m) |
| 2020-03-31 | (m) | $1.38M | (m) | (m) | (m) | $35.72M | (m) | (m) | (m) | $4.24M | (m) |
| 2019-12-31 | (m) | $2.60M | (m) | (m) | (m) | $40.20M | (m) | (m) | (m) | $4.21M | (m) |
| 2019-09-30 | (m) | $1.67M | (m) | (m) | (m) | $27.70M | (m) | (m) | (m) | $2.80M | (m) |
| 2019-06-30 | (m) | $1.43M | (m) | (m) | (m) | $25.12M | (m) | $188.00K | (m) | $2.07M | (m) |
| 2019-03-31 | (m) | $2.38M | (m) | (m) | (m) | $27.16M | (m) | $368.00K | (m) | $2.03M | (m) |
| 2018-12-31 | (m) | $1.73M | (m) | (m) | (m) | $22.85M | (m) | $552.00K | (m) | $2.61M | (m) |
| 2018-09-30 | (m) | $1.63M | $752.00K | (m) | $2.17M | $18.98M | (m) | $752.00K | $0.00 | $2.17M | $0.00 |
| 2018-06-30 | (m) | $1.66M | $951.00K | (m) | $1.07M | $16.36M | (m) | $951.00K | $0.00 | $1.07M | $0.00 |
| 2018-03-31 | (m) | $1.44M | (m) | (m) | (m) | $15.94M | (m) | (m) | (m) | $1.12M | (m) |
| 2017-12-31 | (m) | $1.54M | (m) | (m) | (m) | $16.55M | (m) | (m) | (m) | $1.19M | (m) |
| 2017-09-30 | (m) | $1.62M | (m) | (m) | (m) | $15.16M | (m) | (m) | (m) | $1.10M | (m) |
| 2017-06-30 | (m) | $1.57M | (m) | (m) | (m) | $13.74M | (m) | (m) | (m) | $2.40M | (m) |
| 2017-03-31 | (m) | $2.22M | (m) | (m) | (m) | $14.90M | (m) | (m) | (m) | $2.20M | (m) |
| 2016-12-31 | (m) | $1.22M | (m) | (m) | (m) | $14.42M | (m) | (m) | (m) | $2.00M | (m) |
| 2016-09-30 | (m) | $1.15M | (m) | (m) | (m) | $14.62M | (m) | (m) | (m) | $872.00K | (m) |
| 2016-06-30 | (m) | $1.55M | (m) | (m) | (m) | $12.68M | (m) | (m) | (m) | $864.00K | (m) |
| 2016-03-31 | (m) | $1.77M | (m) | (m) | (m) | $12.76M | (m) | (m) | (m) | $916.00K | (m) |
| 2015-12-31 | (m) | $1.37M | (m) | (m) | (m) | $12.82M | (m) | (m) | (m) | $774.00K | (m) |
| 2015-09-30 | (m) | $931.00K | (m) | (m) | (m) | $12.43M | (m) | (m) | (m) | $676.00K | (m) |
| 2015-06-30 | (m) | $1.29M | (m) | (m) | (m) | $12.80M | (m) | (m) | (m) | $641.00K | (m) |
| 2015-03-31 | (m) | $1.13M | (m) | (m) | (m) | $11.65M | (m) | (m) | (m) | $341.00K | (m) |
| 2014-12-31 | (m) | $1.13M | (m) | (m) | (m) | $13.29M | (m) | (m) | (m) | $325.00K | (m) |
| 2014-09-30 | (m) | $1.02M | (m) | (m) | (m) | $16.38M | (m) | (m) | (m) | $400.00K | (m) |
| 2014-06-30 | (m) | $1.02M | (m) | (m) | (m) | $12.75M | (m) | (m) | (m) | $265.00K | (m) |
| 2014-03-31 | (m) | $1.04M | (m) | (m) | (m) | $12.48M | (m) | (m) | (m) | $298.00K | (m) |
| 2013-12-31 | (m) | $1.24M | (m) | (m) | (m) | $13.93M | (m) | (m) | (m) | $249.00K | (m) |
| 2013-09-30 | (m) | $748.00K | (m) | (m) | (m) | $11.20M | (m) | (m) | (m) | $243.00K | (m) |
| 2013-06-30 | (m) | $1.01M | (m) | (m) | (m) | $9.54M | (m) | (m) | (m) | $415.00K | (m) |
| 2013-03-31 | (m) | $929.00K | (m) | (m) | (m) | $9.91M | (m) | (m) | (m) | $361.00K | (m) |
| 2012-12-31 | (m) | $1.06M | (m) | (m) | (m) | $10.17M | (m) | (m) | (m) | $105.00K | (m) |
| 2012-09-30 | (m) | $879.00K | (m) | (m) | (m) | $9.29M | (m) | (m) | (m) | $102.00K | (m) |
| 2012-06-30 | (m) | $937.00K | (m) | (m) | (m) | $8.03M | (m) | (m) | (m) | $101.00K | (m) |
| 2012-03-31 | (m) | $825.00K | (m) | (m) | (m) | $7.34M | (m) | (m) | (m) | $68.00K | (m) |
| 2011-12-31 | (m) | $981.00K | (m) | (m) | (m) | $7.60M | (m) | (m) | (m) | $71.00K | (m) |
| 2011-09-30 | (m) | $1.28M | (m) | (m) | (m) | $10.38M | (m) | (m) | (m) | $75.00K | (m) |
| 2011-06-30 | (m) | $1.20M | (m) | (m) | (m) | $8.89M | (m) | (m) | (m) | $82.00K | (m) |
| 2010-12-31 | (m) | $1.32M | (m) | (m) | (m) | $10.92M | (m) | (m) | (m) | $86.00K | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |